0
items
$0
Metformin in Advanced CKD
Should we continue metformin in eGFR under 30 ml/min? The visual abstract by Cristina Popa summarizes the conclusions from the Scottish cohort using target trial methodology.
The first KDIGO ADPKD guideline
The KDIGO ADPKD guideline is a result of a decade of global collaboration between physicians, researchers, advocates, and patients. 240 pages summarized in only 2 pictures, made by Cristina Popa.
REGENCY: A B-Cell Super Destroyer in Lupus
Hunting Primary Hyperaldosteronism: are MRAs a blindfold in adrenal vein sampling?
Pain Coping Skills Training in Diaysis
Can we train to deal with the pain? HOPE trial shows us that non-pharmacological intervention can be an option. Visual abstract by Cristina Popa
Top Stories in Nephrology 2024
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every big nephrology congress. Probably 1st place won’t surprise anyone; it was the anticipated FLOW of the year, but this Top 10 Nephrology Stories definitely includes some unexpected titles
ACEing the management of advanced CKD
Re”FINE”ing the role of non steroidal MRAs in Cardio Kidney Metabolic syndrome
Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment?
2024 #NephJCKidneys vote begins
The Balance of Giving: Understanding Risks for Living Kidney Donors
Heart-burn and Kidney Churn
FLOW- the Visual Abstract
‘FLOW’ing with the Semaglu’TIDE’!
Check the beautiful visual abstract made by NephEdC intern Anjana Gopal, with an appearance of the Gila monster as well.
PRAECISely Predicting Preeclampsia
The SLEEP-HD Visual Abstract
Check out the dreamy Visual Abstract by Cristina Popa
Any sleep potion for insomnia in patients on hemodialysis?
ACE-ing the SPACE Trial: traversing the seas of RAS inhibition in non-cardiac surgery
Unlocking the door to living kidney donor paradise?
This week, nephrologists hope they found the key to no-dialysis-land, where kindness and detailed, multistep interventions make the path to kidney transplant much easier. This was foreseen in our Freely Filtered episode and disputed during #KidneyWK 2023 late-breaking clinical trials session. Still, when it comes to RCTs’ results, will it be Deja Vu or a happy ending?
